Nivedita Pharma Private Limited
About Nivedita Pharma Private Limited
Data last updated:
Nivedita Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2011PTC225928.
The company has an authorised share capital of ₹2.5 Lakh and a paid-up capital of ₹1.24 Lakh. It is led by directors Ritu Agarwal and Anuj Goyal.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 154 1st Floor Csc Cr Park Market No. 1, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.24 Lakh. For the same year it recorded a net profit of ₹1.01 Lakh (net margin 10.9%) and EBITDA of ₹5.25 Lakh (EBITDA margin 56.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹83.3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nivedita Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressUnit No. 154 1st Floor Csc Cr Park Market No. 1, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nivedita Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nivedita Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Nivedita Pharma Private Limited, buy the company report.
Financials of Nivedita Pharma Private Limited
FY 2025 filings availableNivedita Pharma Private Limited reported revenue of ₹9.24 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 56.8% | ||||
| Net Profit Margin | 10.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nivedita Pharma Private Limited, buy the company report.
Board of directors of Nivedita Pharma Private Limited
Nivedita Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritu Agarwal | Director | 07 Oct 2011 | 15 Years 1 Months | Current |
| Anuj Goyal | Director | 16 Nov 2015 | 10 Years 11 Months | Current |
Auditor
Nivedita Pharma Private Limited is audited by KAPOOR MITTAL & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAPOOR MITTAL & ASSOCIATES | FY 2022 | 017729C |
Shareholding
The shareholding of Nivedita Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nivedita Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Nov 2025 | 101199330 | Others | ₹2.25 Cr | Open | |
| 08 Nov 2025 | 101193071 | Others | ₹4.3 Cr | Open | |
| 10 Sep 2025 | 101159311 | Others | ₹3.8 Cr | Open | |
| 05 Jul 2025 | 101130866 | Others | ₹3.5 Cr | Open | |
| 05 May 2025 | 101095698 | Others | ₹4.5 Cr | Open |
Total charge records: 26 View all charges
Legal cases
No court or tribunal cases involving Nivedita Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nivedita Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nivedita Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nivedita Pharma Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Anuj Goyal was appointed as Director on 16 Nov 2015.
20 earlier events are in the company report.
Frequently asked questions
Nivedita Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 October 2011 (15+ years old) and is registered under CIN U74900DL2011PTC225928.
Nivedita Pharma has 2 current directors:
- Ritu Agarwal - Director
- Anuj Goyal - Director
The latest financial statements of Nivedita Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Nivedita Pharma is U74900DL2011PTC225928. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nivedita Pharma was incorporated on 07 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Anuj Goyal was appointed as Director on 16 Nov 2015. Rajesh Kumar Agarwal ceased to be Director on 17 Oct 2015. Ritu Agarwal was appointed as Director on 07 Oct 2011.
The registered office of Nivedita Pharma is at Unit No. 154 1st Floor Csc Cr Park Market No. 1, New Delhi, Delhi, India – 110019.
Nivedita Pharma operates in the pharma industry, in the drug formulation and development segment.
Nivedita Pharma has open charges of ₹83.3 Cr and no satisfied charges on record as per latest MCA filings.
The compliance status of Nivedita Pharma is compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
